Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: Results from the DIANA study

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Krämer, Heike U ^a   Raum, Elke ^a   Rüter, Gernot ^b   Schöttker, Ben ^a   Rothenbacher, Dietrich ^c   Rosemann, Thomas ^d   Szecsenyi, Joachim ^e   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Practice of General Medicine   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Cardiology; Diabetes mellitus; Medical management

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DIURETIC AGENT; EXENDIN 4; GLITAZONE DERIVATIVE; HUMAN INSULIN; INSULIN; INSULIN DERIVATIVE; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GERMANY; GLYCEMIC CONTROL; HEALTH CARE QUALITY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; DERIVATIVE; PRESCRIPTION; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DRUG PRESCRIPTIONS; FEMALE; GERMANY; HEALTHCARE DISPARITIES; HUMANS; HYPOGLYCEMIC AGENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 84871397713     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-88     Document Type: Article

References (34)

1. Rivellese AA, Riccardi G, Vaccaro O. Cardiovascular risk in women with diabetes. Nutr Metab Cardiovasc Dis 2010, 20:474-480. 10.1016/j.numecd.2010.01.008, 20621459.
2. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367:1747-1757. 10.1016/S0140-6736(06)68770-9, 16731270.
3. Hayashi T, Kawashima S, Nomura H, Itoh H, Watanabe H, Ohrui T, Yokote K, Sone H, Hattori Y, Yoshizumi M, Ina K, Kubota K, . the Japan Cholesterol and Diabetes Mellitus Investigation Group Age, gender, insulin and blood glucose control status alter the risk of ischemic heart disease and stroke among elderly diabetic patients. Cardiovasc Diabetol 2011, 10:86. 10.1186/1475-2840-10-86, 3200162, 21978180, the Japan Cholesterol and Diabetes Mellitus Investigation Group.
4. Mercuro G, Deidda M, Piras A, Dessalvi CC, Maffei S, Rosano GM. Gender determinants of cardiovascular risk factors and diseases. J Cardiovasc Med 2010, 11:207-220.
5. Heisler M, Piette JD, Spencer M, Kieffer E, Vijan S. The relationship between knowledge of recent HbA(1c) values and diabetes care understanding and self-management. Diabetes Care 2005, 28:816-822. 10.2337/diacare.28.4.816, 15793179.
6. King DK, Glasgow RE, Toobert DJ, Strycker LA, Estabrooks PA, Osuna D, Faber AJ. Self-efficacy, problem solving, and social-environmental support are associated with diabetes self-management behaviors. Diabetes Care 2010, 33:751-753. 10.2337/dc09-1746, 2845021, 20150299.
7. American Diabetes Association (ADA) Standards of medical care in diabetes - 2010. Diabetes Care 2010, 33(Suppl 1):11-61. American Diabetes Association (ADA).
8. Tschöpe C, Schultheiss HP. Diabetic cardiopathy: pathogenesis, diagnosis and therapy. Internist 2003, 44:806-818. [Article in German], 10.1007/s00108-003-0947-z, 14631577.
9. Ferrara A, Mangione CM, Kim C, Marrero DG, Curb D, Stevens M, Selby JV. Translating Research Into Action for Diabetes Study Group. Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 2008, 31:69-74. 10.2337/dc08-1082, 17934157.
10. Gouni-Berthold I, Berthold HK, Mantzoros CS, Bohm M, Krone W. Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes. Diabetes Care 2008, 31:1389-1391. 10.2337/dc08-0194, 2453666, 18375411.
11. Roe CM, McNamara AM, Motheral BR. Gender- and age-related prescription drug use patterns. Ann Pharmacother 2002, 36:30-39.
12. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24:67-74. 10.1097/00005650-198601000-00007, 3945130.
13. Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34:220-233. 10.1097/00005650-199603000-00003, 8628042.
14. American Diabetes Association (ADA) Executive summary: standards of medical care in diabetes - 2010. Diabetes Care 2010, 33(Suppl 1):4-10. American Diabetes Association (ADA).
15. Lehnert H, Wittchen HU, Pittrow D, Bramlage P, Kirch W, Böhler S, Höfler M, Ritz E. Prevalence and pharmacotherapy of diabetes mellitus in primary care. Dtsch Med Wochenschr 2005, 130:323-328. [Arctile in German], 10.1055/s-2005-863050, 15712019.
16. Schernthaner G, Forst T, Gulba D, Haberbosch W, Hanefeld M, Linss G, März W, Mehnert H, Rosak C, Schnell O, Seufert J, Tschöpe D, Erdmann E. Challenge in diabetes therapy: effects of glitazones beyond blood glucose control. Dtsch Med Wochenschr 2009, 134:949-954. [Article in German], 10.1055/s-0029-1220255, 19384816.
17. Loke YK, Singh S, Furberg CD. Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. CMAJ 2009, 180:32-39. 10.1503/cmaj.080486, 2612065, 19073651.
18. Gemeinsamer Bundesausschuss (GBA) Arzneimittel-Richtlinie/ Anlage III (Glitazone zur Behandlung des Diabetes mellitus Type 2). http://www.g-ba.de/informationen/beschluesse/1141/. 02 July 2012, Gemeinsamer Bundesausschuss (GBA).
19. European Medicines Agency European Medicines Agency recommends suspension of Avandia, Avandamet and Avaglin. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/general/general_content_000420.jsp&mid=WC0b01ac058001d126. 02 July 2012, European Medicines Agency.
20. Lenzen MJ, Rosengren A, op Reimer WJ S, Follath F, Boersma E, Simoons ML, Cleland JG, Komajda M. Management of patients with heart failure in clinical practice: differences between men and women. Heart 2008, 94:e10. 10.1136/hrt.2006.099523, 17575332.
21. Baumhäkel M, Müller U, Böhm M. Influence of gender of physicians and patients on guideline-recommended treatment of chronic heart failure in a cross-sectional study. Eur J Heart Fail 2009, 11:299-303. 10.1093/eurjhf/hfn041, 2645055, 19158153.
22. Nilsson PM, Theobald H, Journath G, Fritz T. Gender differences in risk factor control and treatment profile in diabetes: a study in 229 swedish primary health care centres. Scand J Prim Health Care 2004, 22:27-31. 10.1080/02813430310003264, 15119517.
23. Hasslacher C, Wolf G, Kempe P, Ritz E. Diabetic Nephropathie. Diabetologie und Stoffwechsel 2010, 5(Suppl 2):S113-S116. [Article in German].
24. Brannström J, Hamberg K, Molander L, Lövheim H, Gustafson Y. Gender disparities in the pharmocological treatment of cardiovascular disease and diabetes mellitus in the very old. Drugs Aging 2011, 28:993-1005. 10.2165/11594730-000000000-00000, 22117097.
25. Dallongville J, De Bacquer D, Heidrich J, De Backer G, Prugger C, Kotseva K, Montaye M, Amouyel P. Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event. Heart 2010, 96:1744-1749. 10.1136/hrt.2010.196170, 20956490.
26. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008, 358:580-591. 10.1056/NEJMoa0706245, 18256393.
27. Kearney PM, Blackwell L, Collins R, Keech A, Simes J, Peto R, Armitage J, Baigent C, . Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008, 371:117-125. 10.1016/S0140-6736(08)60104-X, 18191683, Cholesterol Treatment Trialists' (CTT) Collaborators.
28. Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 2009, 58:1634-1640. 10.2337/db08-1771, 2699859, 19411614.
29. Squizzato A, Keller T, Romualdi E, Middeldorp S. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease. Cochrane Database Syst Rev 2011, CD005158.
30. Graversen L, Christensen B, Borch-Johnsen K, Lauritzen T, Sandbaek A. General practitioners' adherence to guidelines on management of dyslipidaemia: ADDITION-Denmark. Scand J Prim Health Care 2010, 28:47-54. 10.3109/02813430903335216, 3440615, 19929180.
31. Fu AZ, Zhang Q, Davies MJ, Pentakota SR, Radican L, Seck T. Underutilization of statins in patients with type 2 diabetes in US clinical practice: a retrospective cohort study. Curr Med Res Opin 2011, 27:1035-1040. 10.1185/03007995.2011.567257, 21410303.
32. Leosdottir M, Willenheimer R, Persson M, Nilsson PM. The association between glucometabolic disturbances, traditional cardiovascular risk factors and self-rated health by age and gender: a cross-sectional analysis within the Malmö preventive project. Cardiovasc Diabetol 2011, 10:118. 10.1186/1475-2840-10-118, 3270001, 22204568.
33. Moebus S, Balijepalli C, Lösch C, Göres L, von Stritzky B, Bramlage P, Wasem J, Jöckel KH. Age- and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factors combinations of the metabolic syndrome -a cross-sectiona study. Cardiovasc Diabetol 2010, 9:34. 10.1186/1475-2840-9-34, 2929217, 20696055.
34. Franconi F, Campesi I, Occhioni S, Tonolo G. Sex-gender differences in diabetes vascular complications and treatment. Endocr Metab Immune Disord Drug Targets 2012, 12:179-196. 10.2174/187153012800493512, 22236023.